BioNTech SE
BNTX
$101.81
$3.053.09%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 17.38B | 18.64B | 18.53B | 16.90B | 18.29B |
Total Receivables | 1.58B | 1.34B | 306.98M | 2.08B | 2.59B |
Inventory | 293.30M | 338.05M | 364.41M | 372.64M | 395.38M |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 220.21M | 307.61M | 384.98M | 363.58M | 310.49M |
Total Current Assets | 19.47B | 20.62B | 19.59B | 19.72B | 21.58B |
|
|||||
Total Current Assets | 19.47B | 20.62B | 19.59B | 19.72B | 21.58B |
Net Property, Plant & Equipment | 1.23B | 1.29B | 1.21B | 1.11B | 1.07B |
Long-term Investments | 394.04M | 417.13M | 399.01M | 397.78M | 400.69M |
Goodwill | 394.04M | 417.13M | 399.01M | 397.78M | 400.69M |
Total Other Intangibles | 794.80M | 974.68M | 923.93M | 886.50M | 864.04M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 145.46M | 195.74M | 225.54M | 187.94M | 206.81M |
Total Assets | 23.33B | 24.98B | 23.83B | 24.01B | 25.43B |
|
|||||
Total Accounts Payable | 441.76M | 850.55M | 944.50M | 322.36M | 391.29M |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 40.89M | 41.71M | 37.82M | 33.77M | 31.06M |
Total Finance Division Other Current Liabilities | 2.13B | 1.92B | 1.62B | 1.38B | 1.87B |
Total Other Current Liabilities | 2.13B | 1.92B | 1.62B | 1.38B | 1.87B |
Total Current Liabilities | 2.61B | 2.81B | 2.60B | 1.73B | 2.29B |
|
|||||
Total Current Liabilities | 2.61B | 2.81B | 2.60B | 1.73B | 2.29B |
Long-Term Debt | -- | -- | -- | 2.48M | 2.65M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 222.28M | 230.09M | 234.97M | 218.69M | 208.47M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 394.14M | 622.24M | 557.59M | 515.27M | 551.45M |
Total Liabilities | 3.23B | 3.67B | 3.39B | 2.47B | 3.05B |
|
|||||
Common Stock & APIC | 257.38M | 277.27M | 266.37M | 268.21M | 274.79M |
Retained Earnings | 19.77B | 21.01B | 19.97B | 20.98B | 21.85B |
Treasury Stock & Other | 66.78M | 30.56M | 196.40M | 292.80M | 258.65M |
Total Common Equity | 20.10B | 21.32B | 20.44B | 21.54B | 22.38B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 20.10B | 21.32B | 20.44B | 21.54B | 22.38B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 20.10B | 21.32B | 20.44B | 21.54B | 22.38B |
|